ARCHIVES

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

This article is from The Cancer Letter archive.

Vol. 15 No. 03 | January 20, 1989

Download PDF Visit The Full Archive

Related Articles

Oncology Nursing Society Names 15 To Advisory Panel.

September 29, 2000

Older Patients Can Do Well With Stem Cell Transplants

March 30, 2007

Henles to Get Bristol-Myers $25,000 Award

March 23, 1979

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

Increase In DCCR Grants May Not Be Possible Without Decreasing Quality, Committee Told

July 28, 1978

Proposed Regulations for Center Grants In Federal Register

October 29, 1976